Acute Mi clinical trials

Explore recruiting acute mi clinical trials.

Recruiting acute mi studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Mi trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)

Spain, Netherlands, Italy

Therapeutic use (Phase IV) EU CTIS Study details

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

ARTEMIS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction.

Greece, Bulgaria, Germany, Poland, Netherlands, Italy +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Belgium, Poland, Hungary, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Mi trials by city

Acute Mi in Toronto Acute Mi in Vancouver Acute Mi in Montreal Acute Mi in Calgary Acute Mi in Edmonton Acute Mi in Ottawa Acute Mi in Winnipeg Acute Mi in Quebec City Acute Mi in Hamilton Acute Mi in Kitchener Acute Mi in London Acute Mi in Halifax Acute Mi in New York Acute Mi in Los Angeles Acute Mi in Chicago Acute Mi in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease